Development-Stage Mock — All Data Illustrative

Licensing marketplace is in active development. Cohort listings are illustrative. Wyoming SF0038 · Not an offer to sell securities.

DATA LICENSING MARKETPLACE

Institutional access to de-identified, consent-verified clinical cohort data. Every query metered on-chain. Every access event recorded. Distribution routes automatically per registered split rules.

Available Cohorts

—

Consent-verified datasets

Active Licenses

—

Institutional agreements

Pending Queries

—

Awaiting authorization

Consenting Patients

—

Across all cohorts

Illustrative Cohort Listings

DEV STAGE MOCK

Diabetes Management Cohort

Type 2 DM · Longitudinal treatment pathways · HbA1c outcomes

PENDING ENROLLMENT

Patients

—

FHIR Resources

3 types

Licensing Tier

Institutional

Consent Type

HIPAA Authorization

Condition(E11.*) · MedicationRequest(metformin, insulin, GLP-1) · Observation(HbA1c, fasting glucose, eGFR)

Cardiovascular Risk Cohort

HTN, CAD, CHF · Risk stratification · Lipid panel longitudinal

PENDING ENROLLMENT

Patients

—

FHIR Resources

4 types

Licensing Tier

Institutional

Consent Type

HIPAA Authorization

Condition(I10-I27) · Observation(lipid panel, BP, BNP) · Procedure(EKG, stress test) · MedicationRequest(statins, ACE-I, beta-blocker)

Oncology Treatment Pathway Cohort

Solid tumors · Treatment response · Survival outcomes

PENDING ENROLLMENT

Patients

—

FHIR Resources

5 types

Licensing Tier

Institutional + IRB

Consent Type

HIPAA + Research Auth

Condition(C-codes) · MedicationRequest(chemo, immunotherapy) · Procedure(surgery, radiation) · Observation(tumor markers, CBC) · DiagnosticReport

Institutional Access Inquiries

Pharmaceutical companies, payers, AI research organizations, and academic institutions can request licensing access. All inquiries reviewed by the DAORX rights administration team.

licensing@daorx.io

Response within 5 business days

All cohort data is de-identified per HIPAA Safe Harbor (45 CFR §164.514(b)) prior to licensing. No individually identifiable health information (IIHI) is transferred in any licensing transaction. Patient consent is verified on-chain via the DAORX consent chaincode before any query is authorized. Wyoming SF0038 · Not an offer to sell securities · MRT-POLICY compliant.

Splits Registration Patient Royalty Dashboard Rights Administration

Wyoming SF0038 · Development-stage · Illustrative mock